SilMA Hydrogel‐Delivered Human Amniotic Epithelial Stem Cells Promote Bone Regeneration Through COL8A1 ‐Mediated Osteogenesis and Angiogenesis With Coupled M2 Polarization
Journal of Biomedical Materials Research Part B: Applied Biomaterials · 2026-11 · 114 (11)
DOI: 10.1002/jbm.b.70195 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part B: Applied Biomaterials, online erschienen am 09.11.2026. Verfasst von Ming Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Osteogenesis, Bone Regeneration, Amnion, Hydrogels. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Anhui Provincial Health Science and Technology Project.
Abstract (Originalsprache)
Critical‐sized bone defects remain a major clinical challenge. Human amniotic epithelial cells (hAECs) hold translational promise for bone regeneration, but the molecular effectors of their paracrine activity are poorly defined. Here, we used an injectable, photocrosslinkable silk fibroin methacryloyl (SilMA) hydrogel as a localized delivery vehicle for hAECs. Integrating bioinformatic mining of the publicly available GSE57265 RNA‐seq dataset with loss‐of‐function validation, we identified COL8A1 as a hub paracrine effector enriched in osteogenically primed hAECs. Transwell assays showed that hAEC secretions enhance hBMSC osteogenesis and HUVEC angiogenesis, and COL8A1 knockdown significantly attenuated both effects, establishing COL8A1 as functionally required for the hAEC secretome. The SilMA hydrogel sustained encapsulated hAEC viability, and systematic characterization of the three formulations identified 15% SilMA as offering the optimal balance between gelation kinetics, mechanical support, degradability and cytocompatibility. Subcutaneous implantation revealed that SilMA/hAECs composites shift macrophage polarization toward an anti‐inflammatory M2 phenotype. In a rat 5‐mm calvarial defect model, SilMA/hAECs enhanced bone regeneration at 4 and 8 weeks, with increased BV/TV, vascular density and osteoblast abundance. This study establishes SilMA‐delivered hAECs—acting through COL8A1 paracrine signaling—as a polymeric‐biomaterial strategy that concurrently engages osteogenic, angiogenic and immunomodulatory programs for bone repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, Jiangsu, China.
- Department of Orthopedics, The Second Affiliated Hospital of Wannan Medical University, Wuhu, Anhui, China.
- Department of Pathology, The Second Affiliated Hospital of Wannan Medical University, Wuhu, Anhui, China.
- Department of Pathology, The First Affiliated Hospital of Wannan Medical University (Yijishan Hospital of Wannan Medical University), Wuhu, Anhui, China.
ORCID-Profile: Ming Li, Wanwan Gao
Förderung
- Anhui Provincial Health Science and Technology Project
Zitieren
APA
Li, M., Li, C., & Gao, W. (2026). SilMA Hydrogel‐Delivered Human Amniotic Epithelial Stem Cells Promote Bone Regeneration Through COL8A1 ‐Mediated Osteogenesis and Angiogenesis With Coupled M2 Polarization. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 114(11). https://doi.org/10.1002/jbm.b.70195
Vancouver
Li M, Li C, Gao W. SilMA Hydrogel‐Delivered Human Amniotic Epithelial Stem Cells Promote Bone Regeneration Through COL8A1 ‐Mediated Osteogenesis and Angiogenesis With Coupled M2 Polarization. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2026;114(11). doi:10.1002/jbm.b.70195
BibTeX
@article{Li2026,
author = {Li, Ming and Li, Chunshuang and Gao, Wanwan},
title = {SilMA Hydrogel‐Delivered Human Amniotic Epithelial Stem Cells Promote Bone Regeneration Through COL8A1 ‐Mediated Osteogenesis and Angiogenesis With Coupled M2 Polarization},
journal = {Journal of Biomedical Materials Research Part B: Applied Biomaterials},
year = {2026},
volume = {114},
number = {11},
doi = {10.1002/jbm.b.70195}
}
EUVIMED